This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Prevalence of Ocular Surface Disease in Glaucoma Patients

This study has been completed.
Information provided by (Responsible Party):
Alcon Research Identifier:
First received: September 27, 2006
Last updated: May 25, 2012
Last verified: September 2007
Demographic information and a brief medical and concomitant medicine history will be obtained from the glaucoma patient's records. Qualified patients will be asked to complete a questionnaire about their symptoms. Patients will then be scheduled to undergo three standard clinical tests of the ocular surface.

Condition Phase
Glaucoma Phase 4

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Prevalence of Ocular Surface Disease in Glaucoma Patients

Resource links provided by NLM:

Further study details as provided by Alcon Research:

Enrollment: 101
Study Start Date: September 2006
Study Completion Date: February 2007
Primary Completion Date: February 2007 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients 18 years or older with open-angle glaucoma or ocular hypertension were consecutively recruited for the study.

Inclusion Criteria:

  • Diagnosis of glaucoma;
  • Other protocol-defined inclusion criteria may apply.

Exclusion Criteria:

  • Inability to understand trial procedures;
  • Inability to understand Informed Consent;
  • Current use or use within the last 3 months of Restasis, steroids, or topical ocular non-steroidal anti-inflammatory drugs;
  • Punctal plugs;
  • Previous glaucoma, corneal, or conjunctival surgery;
  • Other protocol-defined exclusion criteria may apply.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00382122

United States, California
La Jolla
La Jolla, California, United States, 92093
Sponsors and Collaborators
Alcon Research
Study Director: Felipe Medeiros, MD, PhD University of California, San Diego
  More Information

Responsible Party: Alcon Research Identifier: NCT00382122     History of Changes
Other Study ID Numbers: CMS-06-06
Study First Received: September 27, 2006
Last Updated: May 25, 2012

Keywords provided by Alcon Research:
Ocular hypertension
Dry eye
Ocular surface disease

Additional relevant MeSH terms:
Ocular Hypertension
Eye Diseases processed this record on September 21, 2017